JP2010526873A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526873A5 JP2010526873A5 JP2010508327A JP2010508327A JP2010526873A5 JP 2010526873 A5 JP2010526873 A5 JP 2010526873A5 JP 2010508327 A JP2010508327 A JP 2010508327A JP 2010508327 A JP2010508327 A JP 2010508327A JP 2010526873 A5 JP2010526873 A5 JP 2010526873A5
- Authority
- JP
- Japan
- Prior art keywords
- milk fat
- fraction
- vitamin
- lactoferrin
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021243 milk fat Nutrition 0.000 claims 71
- 239000002246 antineoplastic agent Substances 0.000 claims 30
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims 21
- 108010063045 Lactoferrin Proteins 0.000 claims 18
- 102000010445 Lactoferrin Human genes 0.000 claims 18
- 229940078795 lactoferrin Drugs 0.000 claims 18
- 235000021242 lactoferrin Nutrition 0.000 claims 18
- 239000000203 mixture Substances 0.000 claims 16
- 150000002632 lipids Chemical class 0.000 claims 13
- 235000013365 dairy product Nutrition 0.000 claims 12
- 239000000047 product Substances 0.000 claims 12
- 206010028116 Mucosal inflammation Diseases 0.000 claims 11
- 201000010927 Mucositis Diseases 0.000 claims 11
- 235000010469 Glycine max Nutrition 0.000 claims 9
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims 9
- 229960002061 ergocalciferol Drugs 0.000 claims 9
- -1 iron saturated lactoferrin Chemical class 0.000 claims 9
- 229910021645 metal ion Inorganic materials 0.000 claims 9
- 235000001892 vitamin D2 Nutrition 0.000 claims 9
- 239000011653 vitamin D2 Substances 0.000 claims 9
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 8
- 235000013305 food Nutrition 0.000 claims 7
- UOELMDIOCSFSEN-FVZZCGLESA-N 7-Dehydrositosterol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)C=C[C@H](C)C(C)C)=CC=C1C[C@@H](O)CCC1=C.C1[C@@H](O)CCC2(C)C(CC[C@@]3([C@@H]([C@H](C)C=C[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 UOELMDIOCSFSEN-FVZZCGLESA-N 0.000 claims 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 6
- 244000068988 Glycine max Species 0.000 claims 6
- 229930003316 Vitamin D Natural products 0.000 claims 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 6
- 230000000259 anti-tumor effect Effects 0.000 claims 6
- 235000014121 butter Nutrition 0.000 claims 6
- 239000006071 cream Substances 0.000 claims 6
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 claims 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 6
- 229910052742 iron Inorganic materials 0.000 claims 6
- 235000019166 vitamin D Nutrition 0.000 claims 6
- 239000011710 vitamin D Substances 0.000 claims 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 6
- RMDJVOZETBHEAR-LQYWTLTGSA-N vitamin D5 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](CC)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C RMDJVOZETBHEAR-LQYWTLTGSA-N 0.000 claims 6
- 229940046008 vitamin d Drugs 0.000 claims 6
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- DIPPFEXMRDPFBK-FWTXJDITSA-N (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5S)-5,6-dimethylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound [C]1([C@@H]2[CH2][CH2][C@@H]([C@]2([CH2][CH2][CH2]1)[CH3])[C@H]([CH3])[CH2][CH2][C@H](C)[CH]([CH3])[CH3])=[CH][CH]=[C]1[CH2][C@@H](O)[CH2][CH2][C]1=[CH2] DIPPFEXMRDPFBK-FWTXJDITSA-N 0.000 claims 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 3
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 3
- 244000144725 Amygdalus communis Species 0.000 claims 3
- 241000208340 Araliaceae Species 0.000 claims 3
- 206010006895 Cachexia Diseases 0.000 claims 3
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims 3
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 claims 3
- 101500000018 Glycine max 2S albumin small chain Proteins 0.000 claims 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims 3
- 235000021360 Myristic acid Nutrition 0.000 claims 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 3
- 239000005642 Oleic acid Substances 0.000 claims 3
- 235000021314 Palmitic acid Nutrition 0.000 claims 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 3
- 241000241413 Propolis Species 0.000 claims 3
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims 3
- 108010073771 Soybean Proteins Proteins 0.000 claims 3
- 235000021355 Stearic acid Nutrition 0.000 claims 3
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims 3
- DIPPFEXMRDPFBK-UHFFFAOYSA-N Vitamin D4 Natural products C1CCC2(C)C(C(C)CCC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C DIPPFEXMRDPFBK-UHFFFAOYSA-N 0.000 claims 3
- 235000020224 almond Nutrition 0.000 claims 3
- 235000010208 anthocyanin Nutrition 0.000 claims 3
- 239000004410 anthocyanin Substances 0.000 claims 3
- 229930002877 anthocyanin Natural products 0.000 claims 3
- 150000004636 anthocyanins Chemical class 0.000 claims 3
- 239000003173 antianemic agent Substances 0.000 claims 3
- 108010038047 apolactoferrin Proteins 0.000 claims 3
- 235000015155 buttermilk Nutrition 0.000 claims 3
- 239000005018 casein Substances 0.000 claims 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims 3
- 235000021240 caseins Nutrition 0.000 claims 3
- 229940127089 cytotoxic agent Drugs 0.000 claims 3
- 235000007240 daidzein Nutrition 0.000 claims 3
- 229930003935 flavonoid Natural products 0.000 claims 3
- 235000017173 flavonoids Nutrition 0.000 claims 3
- 150000002215 flavonoids Chemical class 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 235000006539 genistein Nutrition 0.000 claims 3
- 229940045109 genistein Drugs 0.000 claims 3
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims 3
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims 3
- 235000008434 ginseng Nutrition 0.000 claims 3
- 239000002955 immunomodulating agent Substances 0.000 claims 3
- 239000004615 ingredient Substances 0.000 claims 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 3
- 229960000367 inositol Drugs 0.000 claims 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims 3
- 150000002515 isoflavone derivatives Chemical class 0.000 claims 3
- 235000008696 isoflavones Nutrition 0.000 claims 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 3
- DNVPQKQSNYMLRS-YAPGYIAOSA-N lumisterol Chemical compound C1[C@@H](O)CC[C@@]2(C)[C@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-YAPGYIAOSA-N 0.000 claims 3
- 235000012661 lycopene Nutrition 0.000 claims 3
- 229960004999 lycopene Drugs 0.000 claims 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims 3
- 239000001751 lycopene Substances 0.000 claims 3
- 239000012528 membrane Substances 0.000 claims 3
- 108010071421 milk fat globule Proteins 0.000 claims 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 3
- 229940012843 omega-3 fatty acid Drugs 0.000 claims 3
- 239000006014 omega-3 oil Substances 0.000 claims 3
- 150000003904 phospholipids Chemical class 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 3
- 235000013824 polyphenols Nutrition 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 229940069949 propolis Drugs 0.000 claims 3
- 229940016667 resveratrol Drugs 0.000 claims 3
- 235000021283 resveratrol Nutrition 0.000 claims 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- 229940001941 soy protein Drugs 0.000 claims 3
- 150000003408 sphingolipids Chemical class 0.000 claims 3
- 239000008117 stearic acid Substances 0.000 claims 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 3
- DIPPFEXMRDPFBK-JPWDPSJFSA-N vitamin D4 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C DIPPFEXMRDPFBK-JPWDPSJFSA-N 0.000 claims 3
- 235000019197 fats Nutrition 0.000 claims 2
- 235000013618 yogurt Nutrition 0.000 claims 2
- 108010009736 Protein Hydrolysates Proteins 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000021185 dessert Nutrition 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 claims 1
- 235000015243 ice cream Nutrition 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000020166 milkshake Nutrition 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 235000008476 powdered milk Nutrition 0.000 claims 1
- 235000015067 sauces Nutrition 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ555163A NZ555163A (en) | 2007-05-14 | 2007-05-14 | Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
| PCT/NZ2008/000105 WO2008140335A2 (en) | 2007-05-14 | 2008-05-14 | Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010526873A JP2010526873A (ja) | 2010-08-05 |
| JP2010526873A5 true JP2010526873A5 (enExample) | 2011-06-30 |
Family
ID=40002768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010508327A Pending JP2010526873A (ja) | 2007-05-14 | 2008-05-14 | 免疫又は血液学的増強、腫瘍の形成又は成長の阻害、及び、癌、癌症状又は癌治療の症状の治療又は予防の方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110182943A1 (enExample) |
| EP (2) | EP2146739A4 (enExample) |
| JP (1) | JP2010526873A (enExample) |
| KR (1) | KR20100024930A (enExample) |
| CN (1) | CN101687017A (enExample) |
| AU (1) | AU2008251145A1 (enExample) |
| CA (1) | CA2687254A1 (enExample) |
| MX (1) | MX2009012348A (enExample) |
| NZ (1) | NZ555163A (enExample) |
| RU (1) | RU2483735C2 (enExample) |
| WO (1) | WO2008140335A2 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2200443B2 (en) | 2007-09-17 | 2021-06-30 | Cornell University | Branched chain fatty acids for prevention or treatment of gastrointestinal disorders |
| PL2211629T3 (pl) * | 2007-10-19 | 2020-11-16 | Fonterra Co-Operative Group Limited | Sposoby podtrzymania albo poprawy wzrostu lub rozwoju kognitywnego |
| ITMI20090836A1 (it) * | 2009-05-14 | 2010-11-15 | Prodotti Formenti Srl | Uso di lattoferrina in associazione ad eritropoietina nella terapia dell'anemia in pazienti neoplastici sottoposti a chemioterapia e in pazienti con insufficienza renale dializzati |
| EP2453892B1 (en) * | 2009-07-16 | 2013-05-29 | Institut National de la Santé et de la Recherche Medicale | Pharmaceutical compositions and their use for treating cancer |
| DE102009049702A1 (de) * | 2009-10-18 | 2011-04-21 | Vczs Venture Capital Zentralschweiz Ag | Verwendung von Lactoferrin und Lactoferrin enthaltende Zusammensetzungen |
| US9938557B2 (en) | 2010-09-16 | 2018-04-10 | The General Hospital Corporation | Red blood cell dynamics for administering treatment for iron-deficiency anemia |
| US20120082719A1 (en) * | 2010-10-05 | 2012-04-05 | Sam Poon Ang | Compositions For Treating Chronic Viral Infections |
| US20120171231A1 (en) * | 2010-12-29 | 2012-07-05 | Anja Wittke | Use of nutritional compositions including lactoferrin in stimulating immune cells |
| CN102600459B (zh) * | 2011-01-20 | 2015-09-23 | 上海转基因研究中心 | 乳铁蛋白在预防和治疗肿瘤转移中的用途 |
| CN103327999B (zh) * | 2011-01-21 | 2016-08-10 | 狮王株式会社 | 促进脂肪分解组合物 |
| EP2711374A4 (en) * | 2011-05-20 | 2014-05-21 | Univ Keio | NEW METAL PROTEIN AND METHOD FOR THE PRODUCTION THEREOF, AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST HORN OR BINDING DAMAGE WITH THIS METAL PROTEIN |
| CN102766206A (zh) * | 2012-07-02 | 2012-11-07 | 北京济福霖生物技术有限公司 | 一种改善缺铁性贫血的产品及其制备方法 |
| CN103372202B (zh) * | 2012-07-23 | 2015-09-16 | 任发政 | 一种含有乳蛋白和脂肪酸的组合物及其制备方法与应用 |
| KR20150038348A (ko) * | 2012-07-27 | 2015-04-08 | 카셈 칼 파르도우씨 | 아연이 존재하지 않는 유지방구(ｍｆｇ)의 약제 조성물 |
| JP5972717B2 (ja) * | 2012-09-03 | 2016-08-17 | 花王株式会社 | 細胞膜強化剤 |
| KR20200096686A (ko) | 2013-02-12 | 2020-08-12 | 엘스 뉴트리션 지에이치 엘티디 | 비-낙농 조제식 |
| US20140274966A1 (en) * | 2013-03-14 | 2014-09-18 | Hygia Pharmaceuticals, Llc | Drink Product Containing Genistein and Use Thereof |
| US20160015776A1 (en) * | 2013-03-15 | 2016-01-21 | Soy Labs, Llc | Products and methods using lunasin enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma |
| EP3048904A2 (en) * | 2013-09-25 | 2016-08-03 | Pronutria Biosciences, Inc. | Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof |
| WO2015081982A1 (de) * | 2013-12-02 | 2015-06-11 | Julius-Maximilians-Universität Würzburg | Pharmazeutische zusammensetzung zur prophylaxe und/oder behandlung von erkrankungen mit einer gestörten lps- und/oder apoptose-regulation |
| WO2015118167A1 (en) * | 2014-02-10 | 2015-08-13 | Institut Curie | Use of mcoln-1 modulators to regulate cell migration |
| CN106535939B (zh) | 2014-07-17 | 2020-08-18 | 益生菌股份公司 | 用于治疗对化疗有抗性的肿瘤的包含褪黑激素和类黄酮的组合物 |
| CA2977910A1 (en) * | 2015-03-05 | 2016-09-09 | Probiotical S.P.A. | Compositions for use in the treatment of tumors resistant to chemotherapy |
| EP3265070B1 (en) * | 2015-03-06 | 2019-07-03 | Repoceuticals ApS | Melatonin for preventing and treating radiation vaginitis and proctitis |
| JP2017002009A (ja) * | 2015-06-15 | 2017-01-05 | 株式会社東洋新薬 | 免疫賦活剤 |
| US10955423B2 (en) | 2015-12-15 | 2021-03-23 | The General Hospital Corporation | Methods of estimating blood glucose and related systems |
| WO2017177192A1 (en) | 2016-04-07 | 2017-10-12 | The General Hospital Corporation | White blood cell population dynamics |
| CA3038327C (en) | 2016-10-03 | 2024-03-12 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
| IT201600128713A1 (it) * | 2016-12-20 | 2018-06-20 | Frima Res Srls | Composizione nel trattamento dell'anemia infiammatoria o da flogosi da malattia cronica |
| US10238618B2 (en) * | 2016-12-29 | 2019-03-26 | The United States Of America As Represented By The Secretary Of The Navy | Compositions and methods for diagnosis and treatment of anemia |
| IT201700050442A1 (it) * | 2017-05-10 | 2018-11-10 | Fusion Farm S R L | Composizione per la prevenzione del danno intestinale |
| US12029765B2 (en) | 2017-06-13 | 2024-07-09 | Houn Simon Hsia | Compositions and methods for treating cancer |
| AU2018354090B2 (en) | 2017-10-23 | 2024-10-24 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
| PL423673A1 (pl) * | 2017-12-01 | 2019-06-03 | Lewandowska Agata | Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis |
| CN112074276A (zh) * | 2018-05-03 | 2020-12-11 | 诺姆奥克塞斯公司 | 一种肌醇基免疫疗法 |
| WO2019226572A1 (en) | 2018-05-23 | 2019-11-28 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
| EP3628169A1 (en) * | 2018-09-25 | 2020-04-01 | DSM IP Assets B.V. | 3h-1,2-dithiol-derivatives for reducing methane emission in ruminants |
| CN109633142B (zh) * | 2018-12-22 | 2021-08-27 | 中国人民解放军第四军医大学 | 一种急性髓细胞性白血病诊断模型的建立方法及其应用 |
| EP3908374A4 (en) | 2019-01-09 | 2022-12-28 | Epitracker, Inc. | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES |
| EP3934639A4 (en) | 2019-03-04 | 2023-01-11 | Epitracker, Inc. | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE DISORDERS, BEHAVIORAL DISORDERS AND CHRONIC PAIN |
| EP3965734A4 (en) * | 2019-05-06 | 2022-12-14 | Arshintseva, Elena Valentinovna | Method for increasing cancer patient's haemoglobin level |
| CN110876803B (zh) * | 2019-11-28 | 2021-04-27 | 中国农业科学院北京畜牧兽医研究所 | 一种包含乳蛋白和油酸的药物组合物 |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
| CN112425658A (zh) * | 2020-11-30 | 2021-03-02 | 黑龙江八一农垦大学 | 一种牛初乳制品及其制备方法和应用 |
| CN112500475B (zh) * | 2020-12-30 | 2022-05-03 | 广州暨南大学医药生物技术研究开发中心有限公司 | 类人乳铁蛋白肽及其应用 |
| US20240342255A1 (en) * | 2021-08-12 | 2024-10-17 | University Of Massachusetts | Targeting 3-ketodihydrosphingosine reductase (kdsr) in cancer |
| WO2023080939A1 (en) | 2021-11-03 | 2023-05-11 | Epitracker, Inc. | Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity |
| CN113880920B (zh) * | 2021-12-06 | 2022-02-22 | 浙江湃肽生物有限公司南京分公司 | 一种亮丙瑞林衍生物及其制备方法 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US5766939A (en) | 1989-05-05 | 1998-06-16 | Baylor College Of Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
| US5571691A (en) | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
| US6100054A (en) | 1989-05-05 | 2000-08-08 | Baylor College Of Medicine | Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms |
| US5849881A (en) | 1989-05-05 | 1998-12-15 | Baylor College Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| US5571697A (en) | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine Texas Medical Center | Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
| IL94183A (en) | 1989-05-05 | 2003-09-17 | Baylor College Medicine | cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE |
| US6066469A (en) | 1990-03-08 | 2000-05-23 | Ferro Dynamics, Inc. | Cloning, expression, and uses of human lactoferrin |
| AUPN271295A0 (en) * | 1995-05-02 | 1995-05-25 | Gropep Pty Ltd | Method of treatment |
| ZA932568B (en) | 1992-04-24 | 1993-11-12 | Baylor College Midecine A Non | Production of recombinant human lactoferrin |
| AU1809895A (en) | 1994-02-16 | 1995-09-04 | Pharming Bv | Isolation of lactoferrin from milk |
| JP3112637B2 (ja) | 1994-09-30 | 2000-11-27 | 雪印乳業株式会社 | 骨強化剤 |
| JP3557011B2 (ja) | 1995-03-30 | 2004-08-25 | 株式会社東芝 | 半導体発光素子、及びその製造方法 |
| JP2974604B2 (ja) | 1996-01-23 | 1999-11-10 | 雪印乳業株式会社 | 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用 |
| US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
| US6111081A (en) | 1996-05-31 | 2000-08-29 | Baylor College Of Medicine | Lactoferrin variants and uses thereof |
| US5985339A (en) * | 1996-11-22 | 1999-11-16 | Kamarei; A. Reza | Refrigeration-shelf-stable ready-to-drink complete nutritional compositions and products |
| EP1017407A2 (en) | 1997-02-03 | 2000-07-12 | Pharming Intellectual Property BV | Useful properties of human lactoferrin and variants thereof |
| FR2762850B1 (fr) | 1997-05-02 | 2000-02-11 | Biocem | Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations |
| US6107287A (en) | 1997-09-25 | 2000-08-22 | The Regents Of The University Of California | Lunasin peptides |
| EP0993781A1 (en) * | 1998-10-13 | 2000-04-19 | Societe Des Produits Nestle S.A. | Improving immune function |
| WO2001006983A2 (en) * | 1999-07-22 | 2001-02-01 | Incell Corporation, Llc | Fatty acids to minimize cancer therapy side effects |
| US20020022052A1 (en) * | 2000-04-06 | 2002-02-21 | Dransfield Charles William | Transdermal delivery system |
| AU2002211776A1 (en) * | 2000-10-17 | 2002-04-29 | Board Of Regents, The University Of Texas System | A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes |
| US20030068385A1 (en) * | 2001-03-23 | 2003-04-10 | Moyer Mary Pat | Accelerated action fatty acid (AAFA) promotes health of normal tissues and minimizes the toxic side effects of chemotherapy |
| JP2002306131A (ja) * | 2001-04-16 | 2002-10-22 | Takara Bio Inc | 食品、飲料又は飼料 |
| US6685971B2 (en) * | 2001-06-28 | 2004-02-03 | Rongxiang Xu | Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| US20030134003A1 (en) * | 2001-10-09 | 2003-07-17 | Medigreen Biotechnology Inc. | Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments |
| JP2003137808A (ja) * | 2001-10-26 | 2003-05-14 | Kakunai Juyotai Kenkyusho:Kk | 新規経腸栄養剤の製造法 |
| SE0203265D0 (sv) * | 2002-11-06 | 2002-11-06 | Coloplus Ab | A feed or food product composition |
| TWI317636B (en) * | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
| AU2003225461A1 (en) * | 2003-04-03 | 2004-10-25 | Medigreen Biotechnology Corporation | Composition and method for supporting cancer treatments |
| CN1565626A (zh) * | 2003-07-01 | 2005-01-19 | 贲晓明 | 乳润 |
| WO2005039318A1 (en) * | 2003-10-16 | 2005-05-06 | Nestec S.A. | Nutritional composition against side effects of chemotherapy of radiotherapy |
| TWI273136B (en) | 2003-11-20 | 2007-02-11 | Animal Technology Inst Taiwan | A method for expressing multiple exogenous proteins in a non-human transformed mammalian milk |
| JP2005289817A (ja) * | 2004-03-09 | 2005-10-20 | Daicho Kikaku:Kk | 抗癌剤 |
| BRPI0509736A (pt) * | 2004-04-09 | 2007-09-25 | Nutricia Nv | composição nutricional completa lìquida adequada para alimentar pacientes caquéticos, produto alimentìcio acondicionado, pó, e, processo para a preparação de um produto lìquido |
| WO2005102296A2 (en) * | 2004-04-23 | 2005-11-03 | Heptagen Limited | Combinations for the treatment of immunoproliferative skin disorders such as psoriasis |
| AU2005269383A1 (en) * | 2004-07-28 | 2006-02-09 | Sd Pharmaceuticals, Inc. | Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof |
| JP2006083089A (ja) * | 2004-09-15 | 2006-03-30 | Morinaga Milk Ind Co Ltd | インターフェロン産生増強剤及び飲食品 |
| US20060068022A1 (en) * | 2004-09-29 | 2006-03-30 | Playford Raymond J | Bioactive agent compositions for repair of cell injuries |
| AU2005296271A1 (en) * | 2004-10-15 | 2006-04-27 | University Of Tennessee Research Foundation | Methods for inducing apoptosis in adipocytes |
| NZ555134A (en) | 2004-11-19 | 2010-07-30 | Fonterra Co Operative Group | Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| WO2006096073A1 (en) | 2005-03-08 | 2006-09-14 | Fonterra Co-Operative Group Limited | High pressure processing of metal ion lactoferrin |
| US20060257493A1 (en) * | 2005-04-28 | 2006-11-16 | Amiji Mansoor M | Nanoparticulate delivery systems for treating multi-drug resistance |
| US20080118589A1 (en) * | 2005-05-11 | 2008-05-22 | Sallie Smith Schneider | Pharmaceutical formulations of rhodiola crenulata and methods of use thereof |
| NZ540633A (en) | 2005-06-09 | 2008-12-24 | Fonterra Co Operative Group | Preparing metal ion-lactoferrin comprising contacting a lactoferrin source with a lactoferrin-binding matrix, contacting the immobilised lactoferrin with a source of metal ions to produce metal ion-lactoferrin |
| EP1937298A4 (en) | 2005-10-14 | 2009-11-11 | Auckland Uniservices Ltd | USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES |
-
2007
- 2007-05-14 NZ NZ555163A patent/NZ555163A/en not_active IP Right Cessation
-
2008
- 2008-05-14 AU AU2008251145A patent/AU2008251145A1/en not_active Abandoned
- 2008-05-14 KR KR1020097025876A patent/KR20100024930A/ko not_active Ceased
- 2008-05-14 WO PCT/NZ2008/000105 patent/WO2008140335A2/en not_active Ceased
- 2008-05-14 JP JP2010508327A patent/JP2010526873A/ja active Pending
- 2008-05-14 MX MX2009012348A patent/MX2009012348A/es not_active Application Discontinuation
- 2008-05-14 EP EP08766954A patent/EP2146739A4/en not_active Withdrawn
- 2008-05-14 RU RU2009146048/15A patent/RU2483735C2/ru not_active IP Right Cessation
- 2008-05-14 EP EP11161639A patent/EP2345418A1/en not_active Withdrawn
- 2008-05-14 CN CN200880022565A patent/CN101687017A/zh active Pending
- 2008-05-14 CA CA002687254A patent/CA2687254A1/en not_active Abandoned
- 2008-05-14 US US12/600,208 patent/US20110182943A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2483735C2 (ru) | Способы иммунной или гематологической стимуляции, ингибирования образования или роста опухоли и лечение или предупреждение злокачественной опухоли, симптомов злокачественной опухоли или симптомов, связанных с лечением злокачественных опухолей | |
| Beermann et al. | Physiological properties of milk ingredients released by fermentation | |
| JP5581071B2 (ja) | ミトコンドリア機能向上剤 | |
| ES2700791T3 (es) | Productos alimenticios a base de cacao | |
| KR20080018917A (ko) | 기능성 식품의 제제화를 위한 포스파티딜세린이 풍부한우유 분획물 | |
| CN112839670A (zh) | 可摄取的制剂 | |
| MX2014006991A (es) | Productos alimenticios a base de grasa. | |
| JP2008255033A (ja) | アミノ酸組成物及び飲食物 | |
| CN102065877B (zh) | 用于维持骨健康或减少骨质流失的组合物和方法 | |
| KR101094693B1 (ko) | 스킨 컨디셔닝제 | |
| JP6158565B2 (ja) | 筋タンパク質合成シグナル増強剤 | |
| JP2013166719A (ja) | Ａｍｐｋ活性化剤 | |
| JPWO2019235451A1 (ja) | 月経随伴症状の処置のための組成物 | |
| JP2016138059A (ja) | 歩行中のつまずき改善剤 | |
| CN108473535A (zh) | 膳食肽 | |
| JP5748441B2 (ja) | シトルリンを有効成分として含有する骨量低下改善剤 | |
| JP2006131626A (ja) | ペプチド | |
| JP2012036209A (ja) | ペプチド | |
| JP6849390B2 (ja) | 関節のこわばり改善剤 | |
| JP2018016560A (ja) | 肩の痛み改善剤 | |
| JP6823397B2 (ja) | 歩行中のつまずき改善剤 | |
| WO2016163400A1 (ja) | 火照り抑制剤 | |
| JP2016138058A (ja) | 肩こり改善剤 | |
| HK1156225A (en) | Milk fat for the treatment of mucositis | |
| ITMI20070160A1 (it) | Gelato o preparato per gelato iperproteico e nutriente procedimento per la sua preparazione e suoi usi |